1-12 of 12
Matthew Collin, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of ATR in Combination with Nucleoside Analogues Eradicates Acute Myeloid Leukaemia in an Orthotopic Murine Xenograft Model

Sarah E Fordham, PhD, Helen J Blair, PhD, Claire J Elstob, PhD, Deepali Pal, PhD, Nicola Curtin, PhD, Paul Milne, PhD, Matthew Collin, MD PhD, Graham H Jackson, MD MBBS, Helen J Marr, MD PhD, Olaf Heidenreich, PhD, Ruth Plummer, John Pollard, PhD, Tobias F. Menne, MD PhD FRCPath, Gail L Jones, MD BMBS, James M Allan, DPhil
Journal: Blood
Blood (2016) 128 (22): 4031.
https://doi.org/10.1182/blood.V128.22.4031.4031
Published: 2016
Journal Articles

Serum and Extracellular Vesicle Micrornas MiR-423, MiR-199 and MiR-93* As Biomarkers for Acute Graft Versus Host Disease

Rachel E Crossland, PhD, Jean Norden, Kim F Pearce, PhD, Mateja Kralj Juric, PhD, Clare Lendrem, Louis A Bibby, Matthew Collin, MD PhD, Hildegard T. Greinix, MD, Anne M Dickinson, PhD
Journal: Blood
Blood (2016) 128 (22): 4545.
https://doi.org/10.1182/blood.V128.22.4545.4545
Published: 2016
Journal Articles

Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT

Christoph Schmid, MD, Myriam Labopin, MD, Hendrik Veelken, Nicolaas P.M. Schaap, MD PhD, Michael Schleuning, Michael Stadler, MD, Juergen Finke, MD, Yves Beguin, MD PhD, Matthew Collin, MD PhD, Per T. Ljungman, MD PhD, Gesine Bug, MD, Didier Blaise, MD PhD, Johanna Tischer, MD, Adrian Bloor, FRCPath, Boris Afanasyev, MDPhD, Sebastian Giebel, MD PhD, Norbert Claude Gorin, Pr, MD PhD, Jordi Esteve, Fabio Ciceri, MD, Bipin N. Savani, MD, Frederic Baron, MD PhD, Audrey Mailhol, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2015) 126 (23): 863.
https://doi.org/10.1182/blood.V126.23.863.863
Published: 2015
Journal Articles

Synergy of Unrelated Donor and Full Intensity Conditioning Breaks the Control of Graft Versus Host Disease By Alemtuzumab

Olivia Laverick, BSc, Amy Publicover, MD, Laura Jardine, MD, Kile Green, BSc, Alan Potter, BSc, Graham H Jackson, MD PhD, Matthew Collin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1206.
https://doi.org/10.1182/blood.V124.21.1206.1206
Published: 2014
Journal Articles

Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease

Rachel E Crossland, PhD, Jean Norden, Matthew Collin, MD PhD, Anne M Dickinson, PhD
Journal: Blood
Blood (2014) 124 (21): 1088.
https://doi.org/10.1182/blood.V124.21.1088.1088
Published: 2014
Journal Articles

Treg Induced Impairment of DC Function and Its Impact on GvH Reactions

Mavin Emily, BSc, Lindsay Nicholson, BSc, MSc, PhD, Rafez Ahmed, BSc, MRes, Matthew Collin, MD PhD, Anne Dickinson, PhD, Xiao-nong Wang, PhD
Journal: Blood
Blood (2014) 124 (21): 3815.
https://doi.org/10.1182/blood.V124.21.3815.3815
Published: 2014
Journal Articles

The Equilibration of Peripheral Blood and Tissue CD3+ T Cell Engraftment Is Influenced by Graft Versus Host Disease Following Reduced Intensity Conditioning Stem Cell Transplantation

Victoria Harries, Rachel Dickinson, PhD, Venetia Bigley, MD, Matthew Collin, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2546.
https://doi.org/10.1182/blood.V116.21.2546.2546
Published: 2010
Journal Articles

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Andrew Charlton, MD, Laura Spence, MD, Venetia Bigley, MD, Natasha Groves, PhD, Geoff Hale, PhD, Sarah Pagan, BSc, Brie E Turner, PhD, Gail Jones, MD, PhD, Graham H Jackson, MD, PhD, Anne M Dickinson, PhD, Matthew Collin, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3333.
https://doi.org/10.1182/blood.V114.22.3333.3333
Published: 2009
Journal Articles

Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition.

Laura Spence, MD, Sophie Hambleton, MD, PhD, Venetia Bigley, MD, Sarah Pagan, Matthew Collin, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2024.
https://doi.org/10.1182/blood.V114.22.2024.2024
Published: 2009
Journal Articles

Regulatory T Cells Prevent Effector T Cell Infiltration Into GvHD Target Tissue by Affecting Chemokine Signaling.

Brie Turner, PhD, Shaheda Ahmed, PhD, Sarah Pagan, Jean Norden, Matthew Collin, MD, PhD, Anne M Dickinson, PhD, Xiao Nong Wang, PhD
Journal: Blood
Blood (2009) 114 (22): 1341.
https://doi.org/10.1182/blood.V114.22.1341.1341
Published: 2009
Journal Articles

Clinical and Genetic Risk Assessment for Overall Survival in Haematopoietic Stem Cell Transplantation (HSCT).

Anne M Dickinson, PhD, Kim F Pearce, CStat, Graham H Jackson, Matthew Collin, MD, PhD, Jean Norden, Ernst Holler, PhD, Heike Bickeboller, Yesilda Balavarca, Vanderson Rocha, Hans-Jochem Kolb, Alvaro Aubano, Ilona Hromadnikova, Petr Sedlacek, Alois Gratwohl
Journal: Blood
Blood (2009) 114 (22): 1189.
https://doi.org/10.1182/blood.V114.22.1189.1189
Published: 2009
Journal Articles

“ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation”.

Karin Landfried, Martin Hausmann, Gerhard Rogler, Daniel Wolff, Anne M Dickinson, PhD, Matthew Collin, MD, PhD, Juergen Finke, Ernst Holler, PhD, Reinhard Andreesen, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1155.
https://doi.org/10.1182/blood.V114.22.1155.1155
Published: 2009